ESSA Pharma Inc
(NAS:EPIX)
$
0.20
(0%)
Market Cap: 9.52 Mil
Enterprise Value: -100.10 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 22/100 ESSA Pharma Inc at Jefferies London Healthcare Conference Transcript
Nov 17, 2022 / 03:15PM GMT
Release Date Price:
$3.37
(-8.92%)
Kevin Strang
Jefferies Financial Group Inc. - Analyst
Hi. My name is Kevin Strang. I'm one of the biotech associates here at Jefferies. It's my pleasure today to introduce ESSA Pharma for a fireside chat. I have here with me, David Parkinson, CEO; Peter Virsik, the COO; and David Wood, the CFO. And it's going to be a fireside-chat format. And with that, thank you for joining us today, management.
David Parkinson
ESSA Pharma Inc. - President, CEO & Director
Appreciate the opportunity. Thank you, Kevin.
Kevin Strang
Jefferies Financial Group Inc. - Analyst
And so yeah, we can just dive in if you wouldn't mind telling me, for those who don't know as well, a little bit about ESSA Pharma, and maybe give us a one-minute intro highlighting your main products.
David Parkinson
ESSA Pharma Inc. - President, CEO & Director
Certainly, well ESSA is a small biopharma company focused on small-molecule development to inhibit androgen male hormone biology. That's particularly
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot